Neuralink Update – January 2025

00:00: Outline

00:53: P1, P2, P3

03:14: Feasibility study

04:35: DJ Seo comments

06:20: Academic work

07:18: Bad reporting- Rachel Levy

10:15: Canada trial- international expansion

12:02: Elon talk at CNS

13:46: Please subscribe.

Jan 8, 2025: CES by Mark Penn, CEO of Stagwell:

⁠https://x.com/ElonClipsX/status/1877222791713337623⁠

Jan 7, 2025: Elon Announces More International Expansion:

⁠https://x.com/NeuraPod/status/1876708688242589775⁠

Nov 25, 2024: Neuralink's CONVOY Study Announcement:

⁠https://x.com/neuralink/status/1861107594645119006⁠

Nov 22, 2024: Romina's Offer:

https://x.com/RominaNejad/status/1859996818601652667⁠

Nov 20, 2024: Neuralink's Canadian Trial Announcement:

⁠https://x.com/neuralink/status/1859321866944401727⁠

Nov 20, 2024: University Health Network Announcement:

https://x.com/UHN/status/1859324169072353488⁠

Sep 29, 2024: Elon Talks at Congress of Neurosurgeons Meeting:

⁠https://youtu.be/huxf36QKbI0?si=oQeksONwxG24Iv9G&t=1710⁠

April 2022: Neura Pod Episode:

⁠https://www.youtube.com/watch?v=3qUhEXwrL74&t=1003s&ab_channel=NeuraPod%E2%80%93Neuralink⁠

Apply for Neuralink's Patient Registry:

https://neuralink.com/patient-registry/⁠

Neura Pod is a series covering topics related to Neuralink, Inc. Topics such as brain-machine interfaces, brain injuries, and artificial intelligence will be explored. Host Ryan Tanaka synthesizes information, shares opinions, and conducts interviews to easily learn about Neuralink and its future.

X: https://www.x.com/neurapod/

Support: https://www.patreon.com/neurapod/

Opinions are my own. Neura Pod receives no compensation from Neuralink and has no formal affiliation to the company. Ryan Tanaka may have an equity stake in Tesla, Neuralink, or any of Elon Musk's companies.

#Neuralink #ElonMusk #Tesla

Latest videos

Neuralink Update — January 2026

14
 min
January 27, 2026

The Man Who Uses Neuralink to Control A Robotic Arm

145
 min
January 15, 2026

Neuralink Update — December 2025

16
 min
December 20, 2025